Google Wearables Track Insulin Resistance
Analysis based on 6 articles · First reported Aug 12, 2026 · Last updated Aug 13, 2026
The announcement strengthens Alphabet Inc.'s position in the health wearables market, potentially boosting demand for Pixel Watch 3 and Fitbit devices. It also signals growing competition in blood-sugar monitoring, which could pressure rivals and benefit component suppliers and health tech companies.
Alphabet Inc.'s Alphabet Inc. announced a new health feature for its wearables that tracks insulin resistance over time, marking a first for consumer tech companies. The feature, announced Wednesday alongside new Pixel smartphones in New York, does not continuously monitor glucose levels but uses AI combined with sensors such as accelerometer, barometer, heart rate, and skin temperature to estimate the body's effort in metabolizing food. The Alphabet Inc. Health app will alert users if insulin resistance shifts, prompting lifestyle changes or physician consultation. The feature will debut on the Pixel Watch 3 and Google — Fitbit. Alphabet Inc. also introduced other health features tracking blood pressure trends and nighttime breathing, bundled as Health Guardian. The insulin feature was developed using training data from over 100,000 individuals. The Pixel Watch 3 starts at $399, with a Stephen Curry edition at $579. Alphabet Inc. is also integrating Abbott Laboratories' Lingo continuous glucose monitor into Alphabet Inc. Health. Competitors like Whoop, Oura Health, and Apple are exploring similar blood-sugar tracking capabilities.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard